Conflict of Interest: Dr. Tepper received grants/research support from Allergan, ATI, BristolMyerSquibb, GSK, MAP, Merck, NuPathe, and Zogenix. He is a consultant for Allergan, ATI, GSK, Helsinn, MAP, Merck, Nautilus, NuPathe, and Zogenix. He serves on the Speakers Bureau for Allergan, GSK, MAP, Merck, Nautilus, and Zogenix. He serves on the Advisory Board for Allergan, ATI, GSK, Merck, MAP, Nautilus, NuPathe, and Zogenix. Dr. Rothrock has no conflicts of interest to report.
Conclusions on Opioids
Article first published online: 27 APR 2012
© 2012 American Headache Society
Headache: The Journal of Head and Face Pain
Special Issue: Proceedings of the Inaugural Southern Headache Society Meeting
Volume 52, Issue Supplement s1, pages 38–39, May 2012
How to Cite
Tepper, S. J. and Rothrock, J. F. (2012), Conclusions on Opioids. Headache: The Journal of Head and Face Pain, 52: 38–39. doi: 10.1111/j.1526-4610.2012.02137.x
- Issue published online: 27 APR 2012
- Article first published online: 27 APR 2012
- Accepted for publication February 20, 2012.